# DATROWAY

NDC: 65597-801
Generic name: Datopotamab Deruxtecan
Labeler / Manufacturer: Daiichi Sankyo Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes: INTRAVENOUS
Marketing started: 20250117

FDA application: BLA761394

## Active ingredients

- DATOPOTAMAB DERUXTECAN: 100 mg/5mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"65597-801"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=65597-801
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2950227c-6230-4ca4-a135-46e44d9424a0